Osteoporosis in Hemophilia

Journal Title: International Blood Research & Reviews - Year 2014, Vol 2, Issue 2

Abstract

Aim: The aim of this paper is to review the pathophysiology, risk factors, prevention and treatment of osteoporosis in persons with hemophilia (PWH). Study Design and Methodology: In a search of PubMed up to September 24, 2013 using as keywords "osteoporosis" and "hemophilia" the author found 61 references, of which only the 22 focused on the aim of this study were revised. Results: Prevention of osteoporosis in PWH is crucial. Risk factors are lack of hematological prophylaxis and development of an inhibitor (antibody) against the deficient coagulation factor, lack of exercise due to chronic pain and loss of joint function (hemophilic arthropathy), low body mass index and abnormal liver function because of viral infection (HIV, HCV). It has not been demonstrated that hemophilia has any effect on osteoclast development and/or osteoblast loss. Hemophilia does not impair mineral Ca/P/K mobilizations and metabolisms. Hemophilia does not have any general effects on the endocrine system. Substitution treatment with clotting factors does not interfere with the treatment of osteoporosis. Conclusion: Continuous primary hematological prophylaxis and rehabilitation and exercise are paramount in PWH. PWH over the age of 50 should have routine screening for detection of osteoporosis. In PWH prevention should encourage good habits (such as a diet adequate in calcium and vitamin D) and discourage harmful habits (such as tobacco, alcohol and immobilization). Osteoporosis is multi-facial. Osteoporosis ought to be promptly treated regardless of the underlying cause.

Authors and Affiliations

E. Carlos Rodriguez-Merchan

Keywords

Related Articles

Serum Leptin and Adiponectin Levels in de Novo Acute Myeloid Leukemia Patients: Correlation with Clinical Characteristics

Aim of the Study: Acute myeloid leukemia (AML) is a heterogeneous clonal stem cell malignancy characterized by proliferation of immature hematopoietic cells. Adipokines in particular leptin and adiponectin are highly act...

Occult Hepatitis B Virus Infection among Blood Donors; North Middle Libya

Background: Post transfusion hepatitis B (PTHB) continues to be an important public health concern in regard to blood transfusion in Libya. The inclusion of tests specifically for the hepatitis B surface antigen (HBsAg)...

Myoglobin Status in Stable Patients with Chronic Kidney Disease

Aim: To measure serum myoglobin concentration in stable patients with chronic kidney disease (CKD) who had not commenced hemodialysis and determine its relationship with cardiovascular risk factors. Study Design: Cross-s...

An Immunohistochemical Study of PRAME Expression in Non-hodgkin’s Lymphoma

Aim: Preferentially expressed antigen of melanoma (PRAME) is a cancer-testis antigen with very low/no expression in normal tissues. PRAME is an important target for tumor immunotherapy. Prognostic and in some tumors pred...

The Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Students of Sultan Abdurrahaman School of Health Technology Gwadabawa, Sokoto, North-Western Nigeria

Background: The aim of this study was to determine the prevalence of the deficiency of Glucose-6-phosphate 10 dehydrogenase (G6PD) activity among students of Sultan Abdurrahaman School of Health Technology Gwadabawa, Sok...

Download PDF file
  • EP ID EP242436
  • DOI 10.9734/IBRR/2014/7122
  • Views 98
  • Downloads 0

How To Cite

E. Carlos Rodriguez-Merchan (2014). Osteoporosis in Hemophilia. International Blood Research & Reviews, 2(2), 48-55. https://europub.co.uk/articles/-A-242436